Central Trust Company’s Encompass Health EHC Stock Holding History

Central Trust Company’s Portfolio EHC Stock Details EHC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$7.54K	Buy	78 +38	+95%	+$3.9K	﹤0.01%	1205
2025 Q4	$4.25K	Buy	40 +3	+8%	+$348	﹤0.01%	1253
2025 Q3	$4.7K	Hold	37	–	–	﹤0.01%	1213
2025 Q2	$4.54K	Hold	37	–	–	﹤0.01%	1225
2025 Q1	$3.75K	Hold	37	–	–	﹤0.01%	1251
2024 Q4	$3.42K	Hold	37	–	–	﹤0.01%	1255
2024 Q3	$3.58K	Hold	37	–	–	﹤0.01%	1199
2024 Q2	$3.17K	Hold	37	–	–	﹤0.01%	1229
2024 Q1	$3.06K	Sell	37 -39	-51%	-$2.86K	﹤0.01%	1231
2023 Q4	$5.07K	Hold	76	–	–	﹤0.01%	1159
2023 Q3	$5.11K	Buy	76 +37	+95%	+$2.54K	﹤0.01%	1137
2023 Q2	$2.64K	Hold	39	–	–	﹤0.01%	1154
2023 Q1	$2.11K	Hold	39	–	–	﹤0.01%	1187
2022 Q4	$2.33K	Hold	39	–	–	﹤0.01%	1146
2022 Q3	$2K	Sell	39 -10	-20%	-$500	﹤0.01%	1191
2022 Q2	$2K	Hold	49	–	–	﹤0.01%	1208
2022 Q1	$3K	Buy	+49	New	+$2.56K	﹤0.01%	1200
2021 Q4	–	Sell	-346	Closed	-$21K	–	1278
2021 Q3	$21K	Buy	+346	New	+$21.8K	﹤0.01%	912
2019 Q1	–	Sell	-1,014	Closed	-$50K	–	1108
2018 Q4	$50K	Buy	+1,014	New	+$57.7K	﹤0.01%	634

Other funds holding EHC

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return

Central Trust Company's EHC Position: Q1 2026 in Review

Central Trust Company increased its Encompass Health (EHC) stake by 95% in Q1 2026, buying an estimated $3.9K and bringing the position to 78 shares worth $7.54K. The position accounts for ﹤0.01% of the portfolio, ranked #1205.

Central Trust Company first reported a position in EHC in Q4 2018 and has held it in 19 quarters since. The position peaked at $50K in Q4 2018. 578 funds tracked by Wall St. Rank hold EHC as of Q1 2026.

Central Trust Company held 78 shares of Encompass Health worth $7.54K as of Q1 2026.
Central Trust Company bought 38 Encompass Health shares in Q1 2026, an estimated $3.9K.
Encompass Health made up ﹤0.01% of Central Trust Company's portfolio in Q1 2026, its #1205 holding.
Central Trust Company first reported a position in Encompass Health in Q4 2018 and has held it in 19 quarters since.
Central Trust Company's Encompass Health position peaked at $50K in Q4 2018.
578 funds tracked by Wall St. Rank held Encompass Health as of Q1 2026.

Based on Central Trust Company's 13F filing for Q1 2026, filed 17 Apr 2026.